$VTR

Ventas (VTR) and Welltower (WELL) raised 2026 guidance and increased dividends. Ventas offers a higher current yield (2.4%) while Welltower has faster dividend growth (15% increase). Both have similar payout safety, but Welltower has lower debt. Ventas focuses on U.S. communities, while Welltower expands internationally.

Five REITs specializing in senior housing are highlighted due to a growing demand-supply gap driven by aging baby boomers. Welltower (WELL) and Ventas (VTR) report strong occupancy and revenue growth, while Omega Healthcare (OHI) offers a high yield but faces tenant credit risks. LTC Properties (LTC) and National Health Investors (NHI) are transitioning to more operating models. Key financial metrics and risks are detailed for each.

Ventas (VTR) targets 15-17% NOI growth and expands its acquisition budget to $3 billion, according to Guinness Global Real Assets Fund's Q3 2026 investor letter. The healthcare REIT's stock has traded between $67.36 and $101.60 over the past 52 weeks, closing at $83.54 on October 12, 2026, with a market cap of $43.11 billion. The fund notes potential benefits from improving senior housing occupancy and limited new supply.

Healthcare REITs like Ventas, Welltower, Healthpeak, and American Healthcare REIT are shifting focus to senior housing, moving away from medical office space. Welltower invested $15.5B in senior housing this year and sold $6B in medical office space. New entrants, including private equity and institutional capital, are now targeting medical office properties. Analysts expect $30B in healthcare REIT acquisitions by 2026.

BMO Capital analyst Juan C. Sanabria reiterated a Buy rating on Ventas (VTR) with a $107.00 price target. Ventas reported Q2 revenue of $1.73B and net profit of $74.11M, up from $1.42B and $68.26M respectively last year. The consensus rating is Moderate Buy with a $99.93 target.

Five senior housing REITs raised dividends in 2026, driven by strong demand. Welltower (WELL) and Ventas (VTR) lead in operating exposure, while Omega (OHI) and CareTrust (CTRE) focus on tenant credit and coverage. Dividend yields and coverage ratios vary, with Welltower offering the deepest buffer. Growth is fueled by acquisitions and equity raising, but risks include integration and operator stability.

Welltower (WELL), Ventas (VTR), Omega (OHI), and CareTrust (CTRE) report strong Q2 2026 results, driven by senior housing demand. Welltower and Ventas saw SHOP NOI growth of 21% and 16%. Omega's dividend is covered by AFFO, but faces risks from Genesis Healthcare. CareTrust grew revenue 88% and maintains a strong balance sheet. All companies benefit from aging population trends.

Evercore ISI reduced its price target for Ventas from $101 to $100 but maintained an Outperform rating. The company's stock is currently trading at $86.69, with a 5-day change of -1.16% and a year-to-date change of +12.03%.

Ventas, Inc. (VTR), a healthcare REIT, has outperformed the State Street Real Estate Select Sector SPDR ETF (XLRE) with a 29.6% gain over the past year. VTR's Q2 2026 earnings beat expectations, with revenue of $1.7 billion and adjusted FFO of $0.97. The company has a market cap of $45.2 billion and operates 1,450 properties. Analysts have a 'Strong Buy' consensus with a mean price target of $102, suggesting a 15.7% upside.

Welltower (WELL), Ventas (VTR), and Omega (OHI) are REITs benefiting from a growing demand for senior housing. Welltower reported 20.5% NOI growth, Ventas raised its investment target to $4.5B, and Omega faces tenant credit risks. The aging population is driving demand, while supply remains low.